Modulating Amyloid-β Toxicity: In Vitro Analysis of Aβ42(G37V) Variant Impact on Aβ42 Aggregation and Cytotoxicity
International Journal of Molecular Sciences · 09.12.2024 · 25 (23) · 13219
DOI: 10.3390/ijms252313219 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.12.2024. Verfasst von Shu-Hsiang Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, MacKay Medical College, New Taipei City 252, Taiwan. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Reactive Oxygen Species, Peptide Fragments, Protein Aggregates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, ROC, Mackay Medical College.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is primarily driven by the formation of toxic amyloid-β (Aβ) aggregates, with Aβ42 being a pivotal contributor to disease pathology. This study investigates a novel agent to mitigate Aβ42-induced toxicity by co-assembling Aβ42 with its G37V variant (Aβ42(G37V)), where Gly at position 37 is substituted with valine. Using a combination of Thioflavin-T (Th-T) fluorescence assays, Western blot analysis, atomic force microscopy (AFM)/transmission electron microscopy (TEM), and biochemical assays, we demonstrated that adding Aβ42(G37V) significantly accelerates Aβ42 aggregation rate and mass while altering the morphology of the resulting aggregates. Consequently, adding Aβ42(G37V) reduces the Aβ42 aggregates-induced cytotoxicity, as evidenced by improved cell viability assays. The possible mechanism for this effect is that adding Aβ42(G37V) reduces the production of reactive oxygen species (ROS) and lipid peroxidation, typically elevated in response to Aβ42, indicating its protective effects against oxidative stress. These findings suggest that Aβ42(G37V) could be a promising candidate for modulating Aβ42 aggregation dynamics and reducing its neurotoxic effects, providing a new avenue for potential therapeutic interventions in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, MacKay Medical College, New Taipei City 252, Taiwan.
- Department of Biochemistry, School of Medicine, Tzu Chi University, Hualien City 970, Taiwan.
ORCID-Profile: Je-Wen Liou, Yi-Cheng Chen
Förderung
- Ministry of Science and Technology, ROC
- Mackay Medical College
Zitieren
APA
Huang, S. H., Fang, S. T., Yang, C. H., Liou, J. W., & Chen, Y. C. (2024). Modulating Amyloid-β Toxicity: In Vitro Analysis of Aβ42(G37V) Variant Impact on Aβ42 Aggregation and Cytotoxicity. International Journal of Molecular Sciences, 25(23), 13219. https://doi.org/10.3390/ijms252313219
Vancouver
Huang SH, Fang ST, Yang CH, Liou JW, Chen YC. Modulating Amyloid-β Toxicity: In Vitro Analysis of Aβ42(G37V) Variant Impact on Aβ42 Aggregation and Cytotoxicity. International Journal of Molecular Sciences. 2024;25(23):13219. doi:10.3390/ijms252313219
BibTeX
@article{Huang2024,
author = {Huang, Shu-Hsiang and Fang, Shang-Ting and Yang, Chin-Hao and Liou, Je-Wen and Chen, Yi-Cheng},
title = {Modulating Amyloid-β Toxicity: In Vitro Analysis of Aβ42(G37V) Variant Impact on Aβ42 Aggregation and Cytotoxicity},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {23},
pages = {13219},
doi = {10.3390/ijms252313219}
}
EUVIMED